Duncan Bucknell's IP ThinkTank Gobal Week in Review
Click on the link above to see this week's selection of top intellectual property news breaking in the blogosphere and on the internet.
Click on the link above to see this week's selection of top intellectual property news breaking in the blogosphere and on the internet.
In re Lister (Fed. Cir. 2009) reviewed by Dennis Crouch at Patently-O at the link above: This case is akin to other "library" cases where prior art is found covered in dust in a secluded section of a library. In those cases, the material is considered public if "it could be located by persons interested and ordinarily skilled in the subject matter or art exercising reasonable diligence." Here, the court found that the Library of Congress records did not create accessibility because those records were (at that time) not searchable by subject or keyword. Rather the LOC records could on be searched by title (beginning with the first word of the title of the article) or author last name.
Click on the link above to check out IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.
Click on the link above to see this week's selection of top intellectual property news breaking in the blogosphere and on the internet.
President Obama's speech today focused on its newly formed "strategy for American innovation" -- his "strategy to foster new jobs, new businesses, and new industries by laying the groundwork and the ground rules to best tap our innovative potential. . . . [R]ooted in a simple idea: that if government does its modest part, there's no stopping the most powerful and generative economic force that the world has ever known, and that is the American people. . . . [Beginning with] the building blocks of innovation: education, infrastructure, research." - via Dennis Crouch at Patently-O
"Suddenly the new media comes along and the rules are different. You're not renting an audience, you're building one," says Seth Godin in an interesting blog post at the link above.
Social media is like "word of mouth" on steroids.
From the which-do-you-think dept at TechDirt, Mike Masnick has some thoughts about the Patent Troll Tracker defamation case, at the link in the headline above.
Joe Mullin, a reporter at IP Law & Business, reports on his blog, The Prior Art, that plaintiff Eric Albritton and defendants Cisco Systems and Rick Frenkel, a former Cisco lawyer who blogged anonymously as the Patent Troll Tracker, settled the case Monday night, shortly after Judge Richard Schell ruled that the jurors would have to find "actual malice" on the part of Frenkel and Cisco in order for Albritton to win the punitive damages he was seeking from the tech giant.
It’s a testament to all the great work being carried out by the faculty and grad students in the 7,000 plus labs at the University, by the business school’s entrepreneurship center and by the talented entrepreneurs and investors who stepped up to take fledgling ideas and transform them into commercial ventures.
Click on the link above to check out IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.
Click on the link above to see this week's selection of top intellectual property news breaking in the blogosphere and on the internet.
IPO has now concluded its annual meeting here in Chicago, where one of the many highlights was David Kappos serving as the "kick-off" speaker. In his speech (now posted on the USPTO site), Kappos discussed future plans and goals for the USPTO. Peter Zura's 271 Patent Blog has the highlights at the link above.
Legal bloggers writing about intellectual property matters are sure to take note of a trial set to start Monday in Tyler, Texas. It pits East Texas intellectual property litigator Eric Albritton against Silicon Valley tech company Cisco Systems Inc.
Click on the link above to see this week's selection of top intellectual property news breaking in the blogosphere and on the internet.
Click on the link above to check out IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.
Kodak is sharing lessons learned to help your business grow. Kodak has put a booklet together to share some of their thoughts and first-hand experiences using social media for its business. Download the pdf from Kodak's website at the link in the headline above.
1. An always-on newsletter. IBM is the world’s largest technology company. It is also the world’s tweetingest, with over 1,000 employees using it. The primary purpose is for IBM employees to share information with coworkers as well as the partners, customers, vendors, analysts and editors who comprise the company’s huge global ecosystem. According to IBM’s social media manager Adam C. Christensen (@AdamClyde), IBMers are involved in thousands of tweeted conversations every day. It allows them to share information fast and out on the edge, without the tedium of filtering from corporate headquarters. “Twitter makes us a smarter company,” he said. Shel Israel, author of the recently published book "Twitterville" has 5 more ways companies can use Twitter. Click on the link in the headline above.
BioWorld Today posted an article last week about the top 25 biotech drugs currently on the market. Written by Michael Harris, Executive Editor, the piece represents a précis of a longer report by BioWorld, entitled "Market-Leading Biotechnology Drugs 2009: Blockbuster Dynamics in an Ailing Economy." Kevin Noonan at Patent Docs reviews the article at the link above.
Click on the link above to check out IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.
Patent-hoarding giant Intellectual Ventures has long beat the drum that it doesn't file lawsuits. But now Intellectual Ventures has started selling some of its 27,000 patents to people who aren't afraid to sue -- and in some cases IV will get a share of the prize. It's a scary scenario for tech companies that may end up in the legal crosshairs, but industry observers say it was only a matter of time.